Patents by Inventor Merav Yoeli-Lerner

Merav Yoeli-Lerner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptides and antibodies to MUC 1 proteins
    Patent number: 7897351
    Abstract: The invention relates to methods of inhibiting proliferation or growth of tumor cells and/or inducing cell death in cancer cells. This invention relates to the use of antibodies, hybridomas and pharmaceutical compositions containing same, for inhibiting growth or proliferation and inducing death in epithelial, colon, lung, breast and ovarian tumor cells or other cells which express MUC1 proteins.
    Type: Grant
    Filed: July 17, 2007
    Date of Patent: March 1, 2011
    Assignee: Ramot at Tel-Aviv University Ltd.
    Inventors: Daniel H. Wreschner, Nechaama Ina Smorodinsky, Merav Yoeli-Lerner
  • PEPTIDES AND ANTIBODIES TO MUC 1 PROTEINS
    Publication number: 20080014210
    Abstract: The invention relates to methods of inhibiting proliferation or growth of tumor cells and/or inducing cell death in cancer cells. This invention relates to the use of antibodies, hybridomas and pharmaceutical compositions containing same, for inhibiting growth or proliferation and inducing death in epithelial, colon, lung, breast and ovarian tumor cells or other cells which express MUC1 proteins.
    Type: Application
    Filed: July 17, 2007
    Publication date: January 17, 2008
    Applicant: RAMOT AT TEL-AVIV UNIVERSITY LTD.
    Inventors: Daniel Wreschner, Nechaama Smorodinsky, Merav Yoeli-Lerner
  • Peptides and antibodies to muc 1 proteins
    Publication number: 20050019324
    Abstract: The invention relates to methods of inhibiting proliferation or growth of tumor cells and/or inducing cell death relates to the use of antibodies, hybridomas and pharmaceutical compositions containing same, for inhibiting growth or proliferation and inducing death in epithelial, colon, lung, breast and ovarian tumor cells or other cells which express MUC1 proteins.
    Type: Application
    Filed: March 26, 2002
    Publication date: January 27, 2005
    Inventors: Daniel Wreschner, Nechama Smorodinsky, Merav Yoeli-Lerner